The results of the PPI network and Cox regression analyses showed that CXCL10 and CXCL11 are valuable factors involved in the TME of pancreatic cancer and are correlated with the prognosis and clinicopathological characteristics of pancreatic cancer patients. This evidence concerns the gene CXCL10 and familial pancreatic carcinoma.